放射外科
医学
放射治疗
近距离放射治疗
核医学
颅骨
放射科
术中放疗
辐射剂量
辐射
剂量分馏
放射治疗计划
剂量学
立体定向放射治疗
外照射放疗
剂量率
治疗指标
脑瘤
有效剂量(辐射)
剂量分布
射线照相术
放射生物学
同种类的
作者
Hualin Zhang,Phuong Dang Nguyen,Jason C. Ye,Adam Garsa,Aram Sandaldjian Modrek,Zhilei Liu Shen,Salim Balik,Zhengzheng Xu,Kaley E. Woods,Adam Christopher Turner,David G Brachman,Thomas C. Chen,Gabriel Zada,Eric Lin Chang
出处
期刊:Cancers
[Multidisciplinary Digital Publishing Institute]
日期:2026-10-03
卷期号:18 (19): 3201-3201
标识
DOI:10.3390/cancers18193201
摘要
Purpose: Tile-based radiation therapy (TBRT) delivers adjuvant radiation to brain tumor beds using evenly spaced cesium-131 (Cs-131) sources in collagen tiles. This study evaluated TBRT as spatially fractionated radiation therapy (SFRT) across tumor sizes and source counts. Methods and Materials: Dose distributions were generated from postoperative CT scans for 18 patients treated with TBRT, using 10–32 implanted Cs-131 sources per case (median, 20). The resection cavity (RC) was contoured on CT with registered postoperative T1-weighted MRI guidance. CTV_5mm was defined as the RC plus a 5 mm expansion excluding skull and surgical tract, and CTV_5mm_Eval as CTV_5mm minus the RC. Both volumes were analyzed using SFRT dose metrics from the Radiosurgery Society SFRT/Flash working group white paper, and planar high-dose core number density (HCND_A) was used to characterize TBRT spatial fractionation. Results: The mean dose indices of D5 (dose covering 5% of the target volume), D10, D50, D90, D95 and D100 were 175.8 ± 43.3, 148.8 ± 35.1, 86.7 ± 18.5, 56.1 ± 10.5, 50.2 ± 9.0 and 33.4 ± 7.2 Gy for the CTV_5mm_Eval, respectively. The heterogeneity indices, represented by the ratio of D5/D95 and D10/D90, were 3.5 ± 0.6 and 2.7 ± 0.4, respectively, which were in the range of the linac-based Lattice therapy. HCND_A was a constant, TBRT delivered one high dose core for every 1 cm2 of tumor bed. All dose metrics in both the CTV_5mm and CTV_5mm_Eval were largely consistent across all plans. Conclusions: TBRT produced heterogeneous dose distributions comparable to conventional SFRT. A 60 Gy TBRT nominal prescription dose approximated the SFRT D90, or valley dose of the 5 mm expansion target volume, suggesting TBRT may provide an SFRT platform for tile-accessible cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI